Research map: Intracerebroventricular B7-H3-targeting CAR T cells for non-pontine DMG and recurrent/refractory pediatric CNS tumors: a phase 1 trial

Back to the article

Papers in this map

  1. Regression of Glioblastoma after Chimeric Antigen Receptor T-Cell Therapy · Christine E. Brown · 2016 · 1881 citations · Cited by this paper
  2. Comprehensive performance testing and external validation of an AI algorithm to detect and segment brain metastases · 2026 · Related
  3. A single dose of peripherally infused EGFRvIII-directed CAR T cells mediates antigen loss and induces adaptive resistance in patients with recurrent glioblastoma · Donald M. O’Rourke · 2017 · 1838 citations · Cited by this paper
  4. Programmable microfluidic modeling of the glioblastoma immune microenvironment recapitulates temporally regulated tumor-immune signaling · 2026 · Related
  5. Intent-to-treat leukemia remission by CD19 CAR T cells of defined formulation and dose in children and young adults · Rebecca Gardner · 2017 · 1156 citations · Cited by this paper
  6. The prognostic value of CDKN2A/CDKN2B hemizygous deletion in meningioma remains uncertain · 2026 · Related
  7. GD2-CAR T cell therapy for H3K27M-mutated diffuse midline gliomas · Robbie G. Majzner · 2022 · 832 citations · Cited by this paper
  8. The European Association for Neuro-oncology consensus statement on radiation necrosis · 2026 · Related
  9. Immunotherapy response assessment in neuro-oncology: a report of the RANO working group · Hideho Okada · 2015 · 786 citations · Cited by this paper
  10. Point/Counterpoint: Dordaviprone for diffuse midline glioma - A landmark approval or a premature step? · 2026 · Related
  11. A transgene-encoded cell surface polypeptide for selection, in vivo tracking, and ablation of engineered cells · Xiuli Wang · 2011 · 612 citations · Cited by this paper
  12. Genomic hallmarks of depot medroxyprogesterone acetate-associated meningiomas · 2026 · Related
  13. Locoregional delivery of IL-13Rα2-targeting CAR-T cells in recurrent high-grade glioma: a phase 1 trial · Christine E. Brown · 2024 · 342 citations · Cited by this paper
  14. Society news · 2026 · Related
  15. Locoregional infusion of HER2-specific CAR T cells in children and young adults with recurrent or refractory CNS tumors: an interim analysis · Nicholas Alexander Vitanza · 2021 · 329 citations · Cited by this paper
  16. MAPK-driven glioma progression and reprogramming of the tumor-associated immune response · 2026 · Related
  17. Diffuse high-grade gliomas with H3 K27M mutations carry a dismal prognosis independent of tumor location · Michael Karremann · 2017 · 324 citations · Cited by this paper
  18. Professional Grief, Burnout and Coping among Neuro-Oncologists: A Cross-Sectional Online Study (PROGRESS) · 2026 · Related
  19. Intraventricular B7-H3 CAR T Cells for Diffuse Intrinsic Pontine Glioma: Preliminary First-in-Human Bioactivity and Safety · Nicholas Alexander Vitanza · 2022 · 293 citations · Cited by this paper
  20. Carboplatin induces optic nerve oligodendrocyte loss and impairs myelin sheath microstructure in a mouse model of neurofibromatosis type 1 (NF1) · 2026 · Related
  21. Fine-tuning the CAR spacer improves T-cell potency · Norihiro Watanabe · 2016 · 207 citations · Cited by this paper
  22. Characterization of the immune microenvironment of diffuse intrinsic pontine glioma: implications for development of immunotherapy · Nicole A. P. Lieberman · 2018 · 204 citations · Cited by this paper
  23. Tumor inflammation-associated neurotoxicity · Jasia Mahdi · 2023 · 171 citations · Cited by this paper
  24. B7-H3, a potential therapeutic target, is expressed in diffuse intrinsic pontine glioma · Zhiping Zhou · 2012 · 161 citations · Cited by this paper
  25. Small round blue cell tumours: diagnostic and prognostic usefulness of the expression of B7‐H3 surface molecule · Andrea Gregorio · 2008 · 112 citations · Cited by this paper
  26. Administration of B7-H3 targeted chimeric antigen receptor-T cells induce regression of glioblastoma · Xin Tang · 2021 · 100 citations · Cited by this paper
  27. Medulloblastoma: WHO 2021 and Beyond · Jennifer A. Cotter · 2022 · 77 citations · Cited by this paper
  28. Medulloblastoma in the Modern Era: Review of Contemporary Trials, Molecular Advances, and Updates in Management · Margot Lazow · 2022 · 62 citations · Cited by this paper
  29. Relapse patterns in pediatric embryonal central nervous system tumors · Sébastien Perreault · 2013 · 37 citations · Cited by this paper
  30. Locoregional CAR T cells for children with CNS tumors: Clinical procedure and catheter safety · Nicholas Alexander Vitanza · 2023 · 36 citations · Cited by this paper
  31. Locoregional infusion of EGFR806-CAR T cells for recurrent or refractory pediatric CNS tumors: Results of the completed BrainChild02 phase 1 clinical trial · Juliane Gust · 2025 · 25 citations · Cited by this paper
  32. CAR T cell therapy for pediatric central nervous system tumors: a review of the literature and current North American trials · Rebecca J. Ronsley · 2024 · 16 citations · Cited by this paper
  33. Evolving CAR T-Cell Therapy to Overcome the Barriers in Treating Pediatric Central Nervous System Tumors · Andrea Timpanaro · 2025 · 12 citations · Cited by this paper
  34. Pediatric Central Nervous System Embryonal Tumors: Presentation, Diagnosis, Therapeutic Strategies, and Survivorship—A Review · Rebecca J. Ronsley · 2024 · 10 citations · Cited by this paper
  35. Prognostic factors analysis of diffuse midline glioma · Jing Jiang · 2024 · 5 citations · Cited by this paper
  36. Untitled · Cited by this paper
  37. Untitled · Cited by this paper
  38. Untitled · Cited by this paper
  39. Untitled · Cited by this paper

Source: OpenAlex (CC0)